SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (105)11/5/1997 1:21:00 AM
From: scaram(o)uche  Read Replies (1) of 579
 
FEDERAL FILINGS
11/04 Salk Tells Sibia Neurosci Of Intent To Cut Stake-2
Form S-1 333-39389 SEC RECEIVED:
11/04/97
ISSUER: SIBIA NEUROSCIENCES INC.
SYMBOL: SIBI
UNDERWRITER: UBS Securities, Piper Jaffray Inc., and Vector Securities
International Inc.
OFFERING: 2.5 million shares of common stock, including 250,000 shares on
behalf of certain celling shareholders, plus an additional
375,000 shares for over-alotments.
NARRATIVE DESCRIPTION
WASHINGTON (FFBN) The Salk Institute has informed Sibia
Neurosciences Inc. of a desire to liquidate "all or a portion" of its
holdings in Sibia.
As of Nov. 4, The Salk Institute had a 1,983,461 share (21.4%)
stake in Sibia.
Sibia said in the filing that its common stock has a low
trading volume and that sales by the Salk Institute of shares of
company's common stock could have a material adverse effect on the
market price of Sibia's stock.
Officials at Sibia were not immediately available for comment.

/FEDERAL FILINGS CONTACTS: (202) 393-7856 FOR EDITORIAL,
(800) 487-6162 FOR DOCUMENT SALES,
(202) 628-8990 FOR NEWSWIRE SALES,
(888) FED-FILE FOR TECHNICAL SUPPORT,
& fedfil.com //
(END) FEDERAL FILINGS-DOW JONES NEWS 11-04-97
14:
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext